Previous Close | 8.23 |
Open | 8.05 |
Bid | 8.02 x 100 |
Ask | 8.32 x 100 |
Day's Range | 8.00 - 8.74 |
52 Week Range | 3.19 - 14.30 |
Volume | |
Avg. Volume | 803,516 |
Market Cap | 251.327M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Key Insights Significant control over Acrivon Therapeutics by private equity firms implies that the general public has...
Comparing ACRV's Performance to Analyst Projections and Unveiling Key Financials
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...